finasteride has been researched along with Lower Urinary Tract Symptom in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 21 (87.50) | 24.3611 |
| 2020's | 3 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, SR; Covinsky, K; Ensrud, KE; Liu, TT; McVary, KT; Newman, JC; Ricke, WA; Suskind, AM; Walter, LC | 1 |
| Bhojani, N; Nguyen, DD; Trinh, QD | 1 |
| McClure, JA; Welk, B | 1 |
| Ghadian, A; Rezaei, M | 1 |
| Becher, KF; Madersbacher, S; Michel, MC | 1 |
| Culig, Z; Madersbacher, S; Sampson, N | 1 |
| Leverson, GE; Macoska, JA; McVary, KT; Ricke, WA; Uchtmann, KS | 1 |
| Casabé, A; Da Pozzo, LF; Henderson, RJ; Henneges, C; Roehrborn, CG; Sorsaburu, S; Viktrup, L; Wong, DG; Zepeda, S | 1 |
| Burrows, PK; Eggers, PW; Fwu, CW; Kirkali, Z; Kusek, JW; McVary, KT | 1 |
| Berardinelli, F; Cindolo, L; Fanizza, C; Neri, F; Pellegrini, F; Pirozzi, L; Pitrelli, A; Romero, M; Schips, L; Tamburro, FR | 1 |
| Carini, M; Corona, G; Ficarra, V; Gacci, M; Maggi, M; Novara, G; Sebastianelli, A; Serni, S; Shariat, SF; Zattoni, F | 1 |
| Chapple, CR; Osman, N | 1 |
| Büttner, H; Esen, A; Glina, S; Henneges, C; Plekhanov, A; Roehrborn, CG; Sorsaburu, S; Viktrup, L | 1 |
| Cyrus, A; Farmani, E; Goodarzi, D; Kabir, A; Moghimi, M; Moradi, A; Rafiee, M; Shahbazi, E; Talaei, A | 1 |
| Castellan, P; Cindolo, L; De Nunzio, C; Lombardo, R; Pirozzi, L; Presicce, F; Romero, M; Schips, L; Sountoulides, P; Tubaro, A | 1 |
| Cai, W; Guo, Y; Jiang, Y; Li, W; Wang, X; Yang, S | 1 |
| Alcántara-Montero, A; Brenes-Bermúdez, FJ | 1 |
| Alcaraz, A; Baena-González, V; Brenes-Bermúdez, FJ; Carballido-Rodríguez, J; Cózar-Olmo, JM; García-Rojo, D; Manasanch, J; Medina-López, R; Rodríguez-Rubio, F; Ruiz-Cerdá, JL; Unda-Urzaiz, M | 1 |
| Barlow, WE; Goodman, PJ; Hershman, DL; Minasian, LM; Ramsey, SD; Tangen, CM; Thompson, IM; Till, C; Unger, JM; Wright, JD | 1 |
| Kaplan, SA | 1 |
| Carter, HB; Feng, Z; Landis, P; Pierorazio, PM; Ross, AE; Schaeffer, EM; Trock, BJ; Walsh, PC | 1 |
| Chung, DE; Kaplan, SA; Lee, RK; Scofield, S; Te, AE | 1 |
| Autorino, R; Berardinelli, F; Cindolo, L; Fanizza, C; Pirozzi, L; Romero, M; Schips, L | 1 |
| Eggers, PW; Fwu, CW; Kaplan, SA; Kirkali, Z; Kusek, JW; Lee, JY | 1 |
4 review(s) available for finasteride and Lower Urinary Tract Symptom
| Article | Year |
|---|---|
[Do benign prostatic hyperplasia drugs affect mood or cognition?]
Topics: 5-alpha Reductase Inhibitors; Affect; Cognition; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia | 2019 |
Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aging; Diabetes Mellitus; Dihydrotestosterone; Dutasteride; Dyslipidemias; Finasteride; Humans; Inflammation; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Prostatic Hyperplasia; Receptors, Androgen | 2019 |
Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis.
Topics: Adrenergic alpha-1 Receptor Antagonists; Azasteroids; Doxazosin; Dutasteride; Ejaculation; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Sulfonamides; Tamsulosin; Urological Agents | 2014 |
Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride?
Topics: 5-alpha Reductase Inhibitors; Dutasteride; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Treatment Outcome | 2015 |
7 trial(s) available for finasteride and Lower Urinary Tract Symptom
| Article | Year |
|---|---|
The Reduction of Male Lower Urinary Tract Symptoms Is Associated With a Decreased Risk of Death.
Topics: Doxazosin; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Pelvis; Prostate | 2023 |
Combination therapy with omega-3 fatty acids plus tamsulocin and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH).
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Drug Therapy, Combination; Fatty Acids, Omega-3; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Single-Blind Method; Sulfonamides; Tamsulosin; Treatment Outcome; Urological Agents | 2017 |
Prostate Transition Zone Fibrosis is Associated with Clinical Progression in the MTOPS Study.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Biopsy; Cohort Studies; Disease Progression; Doxazosin; Drug Therapy, Combination; Fibrosis; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Time Factors; Treatment Outcome | 2019 |
Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia.
Topics: Aged; Aged, 80 and over; Carbolines; Double-Blind Method; Drug Therapy, Combination; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Tadalafil; Treatment Outcome; Urological Agents | 2014 |
Change in sexual function in men with lower urinary tract symptoms/benign prostatic hyperplasia associated with long-term treatment with doxazosin, finasteride and combined therapy.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Sexuality; Surveys and Questionnaires; Treatment Outcome; Urination | 2014 |
Sexual function in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: results of a 6-month, randomized, double-blind, placebo-controlled study of tadalafil coadministered with finasteride.
Topics: Carbolines; Coitus; Comorbidity; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Tadalafil; Treatment Outcome | 2015 |
Long-term effects of doxazosin, finasteride and combination therapy on quality of life in men with benign prostatic hyperplasia.
Topics: Administration, Oral; Aged; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Doxazosin; Drug Administration Schedule; Drug Therapy, Combination; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Reference Values; Severity of Illness Index; Statistics, Nonparametric; Time; Treatment Outcome | 2013 |
13 other study(ies) available for finasteride and Lower Urinary Tract Symptom
| Article | Year |
|---|---|
Assessment of Frailty and Association With Progression of Benign Prostatic Hyperplasia Symptoms and Serious Adverse Events Among Men Using Drug Therapy.
Topics: Aged; Aged, 80 and over; Disease Progression; Doxazosin; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Finasteride; Follow-Up Studies; Frail Elderly; Frailty; Geriatric Assessment; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Proportional Hazards Models; Prostatic Hyperplasia; Severity of Illness Index; Urological Agents | 2021 |
Combination of Tadalafil and Finasteride for the Treatment of Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Commercialization of the Prescribing Cascade.
Topics: Drug Therapy, Combination; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Tadalafil; Treatment Outcome; Urinary Tract | 2022 |
Clinical effects and economical impact of dutasteride and finasteride therapy in Italian men with LUTS.
Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Aged, 80 and over; Azasteroids; Cohort Studies; Dutasteride; Finasteride; Humans; Italy; Lower Urinary Tract Symptoms; Male; Middle Aged; Retrospective Studies | 2013 |
Contemporary issues with pharmacotherapy for lower urinary tract symptoms.
Topics: 5-alpha Reductase Inhibitors; Dutasteride; Female; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Medication Adherence; Treatment Outcome | 2014 |
Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia.
Topics: Aged; Case-Control Studies; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Middle Aged; Patient Selection; Prazosin; Prostatic Hyperplasia; Treatment Outcome; Urological Agents | 2014 |
Expression of Heat Shock Protein 27 in Benign Prostatic Hyperplasia with Chronic Inflammation.
Topics: Adrenergic alpha-Antagonists; Biomarkers, Tumor; CD3 Complex; Chronic Disease; Cross-Sectional Studies; Disease Progression; Enzyme-Linked Immunosorbent Assay; Finasteride; Gene Expression Regulation; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Humans; Immunohistochemistry; Inflammation; Interleukin-6; Lower Urinary Tract Symptoms; Male; Molecular Chaperones; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Transurethral Resection of Prostate; Tumor Necrosis Factor-alpha | 2015 |
Finasteride or dutasteride for the pharmacological treatment for male lower urinary tract symptoms due to benign prostatic hyperplasia?
Topics: 5-alpha Reductase Inhibitors; Dutasteride; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia | 2016 |
Quality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment--the QUALIPROST study.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Drug Therapy, Combination; Dutasteride; Finasteride; Humans; Longitudinal Studies; Lower Urinary Tract Symptoms; Male; Middle Aged; Phytotherapy; Plant Extracts; Prospective Studies; Prostatic Hyperplasia; Prostatism; Quality of Life; Serenoa; Severity of Illness Index; Sulfonamides; Tamsulosin; Watchful Waiting | 2016 |
Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.
Topics: 5-alpha Reductase Inhibitors; Administrative Claims, Healthcare; Aged; Clinical Trials as Topic; Depression; Finasteride; Follow-Up Studies; Humans; Lower Urinary Tract Symptoms; Male; Medical Record Linkage; Medicare; Middle Aged; Prostatic Neoplasms; Protective Factors; Risk Assessment; Risk Factors; Time Factors; United States | 2016 |
Re: Treatment Satisfaction and Clinically Meaningful Symptom Improvement in Men with Lower Urinary Tract Symptoms and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia: Secondary Results from a 6-Month, Randomized, Double-Blind Study Compari
Topics: Double-Blind Method; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Personal Satisfaction; Prostatic Hyperplasia; Tadalafil; Treatment Outcome | 2016 |
Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer.
Topics: 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Androgen Antagonists; Azasteroids; Biopsy; Disease Progression; Dutasteride; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Retrospective Studies | 2012 |
A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia: finasteride has comparable urinary symptom efficacy and prostate volume reduction, but less sexual side effects and breast complications than dutasteride.
Topics: 5-alpha Reductase Inhibitors; Azasteroids; Drug Substitution; Dutasteride; Ejaculation; Erectile Dysfunction; Finasteride; Gynecomastia; Humans; Libido; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Retrospective Studies | 2012 |
The effects of dutasteride and finasteride on BPH-related hospitalization, surgery and prostate cancer diagnosis: a record-linkage analysis.
Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Aged, 80 and over; Azasteroids; Cohort Studies; Dutasteride; Finasteride; Follow-Up Studies; Hospitalization; Humans; Incidence; Lower Urinary Tract Symptoms; Male; Medical Record Linkage; Middle Aged; Proportional Hazards Models; Prostatic Hyperplasia; Prostatic Neoplasms; Retrospective Studies; Risk Factors; Treatment Outcome | 2013 |